$54.3 Million is the total value of NovaQuest Capital Management, L.L.C.'s 2 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MYOV | MYOVANT SCIENCES LTD. | $48,819,000 | -31.9% | 3,474,645 | 0.0% | 89.99% | +8.4% | |
| RVNC | Sell | REVANCE THERAPEUTICS, INC. | $5,431,000 | -62.9% | 216,038 | -63.9% | 10.01% | -41.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MYOVANT SCIENCES LTD. | 12 | Q3 2020 | 90.0% |
| REVANCE THERAPEUTICS, INC. | 12 | Q3 2020 | 88.1% |
View NovaQuest Capital Management, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-07-24 |
| 13F-HR | 2020-04-24 |
| 13F-HR | 2020-01-24 |
| 13F-HR | 2019-10-25 |
| 13F-HR | 2019-07-29 |
| 13F-HR | 2019-05-08 |
| 13F-HR | 2019-02-12 |
| 13F-HR | 2018-11-07 |
| 13F-HR | 2018-08-01 |
View NovaQuest Capital Management, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.